开云app官网登录入口网页版-官方正版

#多塔利单抗#

0篇内容 | 617人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2214200, encodeId=60692214200e6, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a> <a href='/topic/show?id=4e6c11042e26' target=_blank style='color:#2F92EE;'>#多塔利单抗#</a>, objectTitle=ANNALS OF ONCOLOGY | RUBY试验：多塔利单抗加化疗延长子宫内膜癌患者生存期, objectType=article, longId=833838, objectId=0e7983383870, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240710/1720576829770_92910.png, objectUrl=/article/show_article.do?id=0e7983383870, replyNumber=0, likeNumber=70, createdTime=2024-07-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0e7983383870, moduleTitle=ANNALS OF ONCOLOGY | RUBY试验：多塔利单抗加化疗延长子宫内膜癌患者生存期, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0e7983383870)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187691, encodeId=e704218e69163, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a> <a href='/topic/show?id=4e6c11042e26' target=_blank style='color:#2F92EE;'>#多塔利单抗#</a>, objectTitle=Nat. Commun：多塔利单抗或帕博利珠单抗加化疗治疗既往未经治疗的转移性非鳞状非小细胞肺癌：随机PERLA Ⅱ期试验, objectType=article, longId=813164, objectId=a2dd81316436, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240211/1707656872996_6145188.png, objectUrl=/article/show_article.do?id=a2dd81316436, replyNumber=0, likeNumber=81, createdTime=2024-02-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a2dd81316436, moduleTitle=Nat. Commun：多塔利单抗或帕博利珠单抗加化疗治疗既往未经治疗的转移性非鳞状非小细胞肺癌：随机PERLA Ⅱ期试验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a2dd81316436)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2183340, encodeId=3b292183340e4, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=aa7f8421873' target=_blank style='color:#2F92EE;'>#胸膜间皮瘤#</a> <a href='/topic/show?id=af7b4e36370' target=_blank style='color:#2F92EE;'>#尼拉帕利#</a> <a href='/topic/show?id=4e6c11042e26' target=_blank style='color:#2F92EE;'>#多塔利单抗#</a> <a href='/topic/show?id=f9e5110428d7' target=_blank style='color:#2F92EE;'>#HRR基因突变#</a>, objectTitle=尼拉帕利+多塔利单抗治疗HRR基因突变PD-L1表达晚期NSCLC或胸膜间皮瘤：UNITO-001中期结果, objectType=article, longId=810460, objectId=52a681046061, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=52a681046061, replyNumber=0, likeNumber=75, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=52a681046061, moduleTitle=尼拉帕利+多塔利单抗治疗HRR基因突变PD-L1表达晚期NSCLC或胸膜间皮瘤：UNITO-001中期结果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=52a681046061)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

NSCLC 胸膜间皮瘤尼拉帕利多塔利单抗 HRR基因突变

2024-01-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#子宫内膜癌# #多塔利单抗#

ANNALS OF ONCOLOGY | RUBY试验：多塔利单抗加化疗延长子宫内膜癌患者生存期

2024-07-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #化疗# #帕博利珠单抗# #多塔利单抗#

Nat. Commun：多塔利单抗或帕博利珠单抗加化疗治疗既往未经治疗的转移性非鳞状非小细胞肺癌：随机PERLA Ⅱ期试验

2024-02-16发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#NSCLC# #胸膜间皮瘤# #尼拉帕利# #多塔利单抗# #HRR基因突变#

尼拉帕利+多塔利单抗治疗HRR基因突变PD-L1表达晚期NSCLC或胸膜间皮瘤：UNITO-001中期结果

2024-01-23发表于陕西省

科室
- - 订阅+
  - 更多科室
工具
服务